CapitalStars Financial Research Pvt Ltd


CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market.we specialize in thorough fundamental and technical research analysis in equity and commodity market to provide best equity and commodity tips to traders and investors.we provide intraday as well as delivery stock tips in NSE and BSEand commodity tips in MCX and NCDEX. Read More

Commodity Market Services

Commodity Market Services

In this service we provide 3-4 intraday calls in MCX with a high level of accuracy. The calls are given in Precious Metals, Base Metals and Energies. You can also avail Free Tips for two days to test our accuracy and if satisfied you can join the services with Capital Stars. Read More

Nifty Market Services

Nifty Future Services

We provide you around 1-2 nifty calls, Bank Nifty Futures, nifty futures tips, sgx nifty tips Daily. You can gain more profit, Get 2 days free trial calls. Read More

Equity Market Services

Equity Market Services

In this service we provide 2-4 intraday stock cash calls in NSE/BSE with a high level of accuracy.You can also avail Free Stock Tips for two days to test our accuracy and if satisfied you can join stock cash services with Capital Stars. Read More

Register now

CapitalStars provides Free Trial in Intraday as well as in Positional Services of Equity, Derivatives, and Commodities and Forex Markets. We provide recommendations in NSE, BSE, MCX, NCDEX, and MCX-SX etc. We render you enough entry and exit time in our calls so clients can easily maximize their profits. Read More

Monday, 27 February 2017

CORPORATE NEWS : 27 Feb 2017

Cadila receives USFDA approval for Linezolid Tablets
Cadila receives USFDA approval for Linezolid Tablets (an anti-bacterial agent used to treat certain serious bacterial infections).
The drug will be manufactured at the Pharma SEZ in Ahmedabad – Positive for Cadila.

Axis Bank drops on complaint filed by UIDAI
Shares of Axis Bank dropped on NSE in an otherwise positive market as the report suggests that complaint has been filed against the Bank by UIDAI.
The Unique Identification Authority of India (UIDAI) has filed a criminal complaint against Axis Bank, Suvidhaa Infoserve and eMudhra for allegedly storing biometrics and using them in an unauthorised manner, and all related transaction requests from these organisations have been put on hold.

Tata Motors JLR launches Jaguar XF sedan in India
Tata Motors (JLR) launches locally made Jaguar XF sedan in Indian market at Rs.47.50 lakh; positive read thru
Jaguar Land Rover launched its locally manufactured all-new Jaguar XF sedan at a starting price of Rs. 47.50 lakh (ex-showroom Delhi).The all-new Jaguar XF will be available in two options — a 2-litre Ingenium diesel engine with a power output of 132 kW and a 2-litre petrol engine with a power output of 177 kW.
The new sedan also comes with a slew of advanced technology features, including InControl Touch Pro with the all-new 25.9 cm (10.2) touchscreen infotainment system and a meridian sound system.

Coal India arm approves buy back worth Rs1244.12 cr
Coal India’s arm -Northern coalfields approved buy back worth Rs 1244.12 crore at Rs1.62 lakh per share; positive for Coal India

Lupin’s arm Kyowa enters into agreement with Astellas
Lupin announced that its Japanese subsidiary Kyowa Pharmaceutical Industry Co., Ltd. and Astellas Pharma Inc. have entered into an agreement providing Kyowa the exclusive right to distribute and promote extended-release tablets of quetiapine fumarate in Japan.
Astellas submitted a new drug application (NDA) withthe Ministry of Health, Labour and Welfare in Japan for extended-release tablets of quetiapine fumarate for theindication of improvement of depressive symptoms associated with bipolar disorder.
When Astellas obtains an approval for the new drug application of extended-release tablets of Quetiapine fumarate, based on the agreement, Kyowa will exclusively distribute and promote the products in Japan, Lupin said.

Capitalstars Financial Research Private Limited is a research house and an investment advisory carrying out operations in the Indian Equities and Commodity market.We also provide 2 days free trial to our client.Join our services and trade with us. 
* Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
* CapitalStars Investment Adviser: SEBI Registration Number: INA000001647


  1. I like your blog which is more informative and profitable. There are many blogs in which we can find genuine Comex Tips.